Pavunalimab - Research Grade Biosimilar, CAS [[2329669-78-3]], Unconjugated, Monoclonal

Produktübersicht

• Artikelname: Pavunalimab - Research Grade Biosimilar, CAS [[2329669-78-3]], Unconjugated, Monoclonal
• Artikelnummer: PRS-21-946
• Hersteller Artikelnummer: 21-946
• Alternativnummer: PRS-21-946-0.1
• Hersteller: ProSci
• Kategorie: Antikörper
• Immunogen: Humanized / LAG3, CTLA4
• Konjugation: Unconjugated
• Alternative Synonym: ANTI-CTLA-4/LAG-3 BISPECIFIC ANTIBODY XMAB22841, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS LAG3 (LYMPHOCYTE ACTIVATING 3, LYMPHOCYTE-ACTIVATION 3, CD223)) AND ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4,

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: batch dependent
• NCBI: 3902
• UniProt: P18627
• Puffer: PBS buffer pH 7.5
• Quelle: CHO cells
• Reinheit: >95%
• CAS Nummer: [2329669-78-3]

Anwendungsbeschreibung

• Application Verdünnung: For research use only .